Transplantation & Cellular Therapy Program

Appointments Dr. John Mageneau with a bone marrow transplant patient
  • Overview
  • Our Approach
  • Who We Treat
  • Services
  • Appointments
  • Research
  • Locations
  • Doctors

    • The University of Michigan Health Transplantation and Cellular Therapy Program offers advanced treatment options for those with hematologic cancers and other diseases. 

    Blood and bone marrow transplant along with Cellular therapy and gene therapy are personalized treatments for cancerous and non-cancerous blood diseases. U-M Health is at the forefront of these treatments as a long-standing clinical care team offering it as standard of care as well as in ongoing clinical trials to help bring the latest options to patients.   

    Our Approach

    U-M Health offers advanced treatment options for those with hematologic cancers and other blood disorders. Treatments are made up of BMT, gene therapies, CAR T, and other cellular therapies.   

    We offer a team of specialists, blending compassionate patient care and the latest research to provide expertise, innovation and a personalized approach to our patients and caregivers.   

    Blood & Marrow Transplant (Pediatric) and Cellular Therapy (Pediatric) programs are available for both adult and pediatric patients at C.S. Mott Children's Hospital.   

    Who We Treat

    We offer personalized treatment for those with blood cancers along with those with non-cancerous blood disorders.  

    Services

    Appointments

    To schedule an appointment:  

    Patients: 734-647-8902  

    Healthcare Providers: M-LINE 800-962-3555  

    Research

    Behind the growth and success of the Transplantation and Cellular Therapy program is its commitment to research. Through groundbreaking basic, translational and clinical research efforts, the University of Michigan has become an international leader in understanding and responding to the particular risks and consequences associated with BMT and cellular therapies.  

    In particular, Rogel Cancer Center researchers are at the forefront of the study and treatment of graft-vs.-host disease (GVHD), one of the most common and dangerous consequences of allogeneic transplantation. Along with early clinical trials for CAR T-cell in pediatric and adult patients. Because of this commitment to research, every patient can benefit from the very latest innovations to make these treatment options safer and more effective. 

    Christie Byrne and Kim Zapor Cancer AnswerLine nurses

    Questions about cancer?

    Contact our Cancer AnswerLine™ at 800-865-1125. You'll talk to a nurse with years of experience in cancer care.

    Learn More

    Locations
    • Bone Marrow Transplant & Leukemia Clinic | C. S. Mott Children's Hospital 1540 E Hospital Dr
      Floor 7 Reception B
      Ann Arbor, MI 48109-4257       Get Directions

    Doctors

     Search for a U-M Health doctor     Michigan Photo

    Sarah Marie Anand, MD

    Clinical Assistant Professor

    Hematology, Medical Oncology, Internal Medicine

    Marcus Johannes Geer, MD

    Marcus Johannes Geer, MD

    Clinical Assistant Professor

    Hematology, Internal Medicine, Medical Oncology

    Monalisa Ghosh, MD

    Monalisa Ghosh, MD

    Clinical Associate Professor

    Medical Oncology, Internal Medicine

    Darren Patrick King, MD

    Clinical Assistant Professor

    Hematology, Medical Oncology, Internal Medicine

    John Joseph Maciejewski, MD

    John Joseph Maciejewski, MD, PhD

    Clinical Assistant Professor

    Hematology, Internal Medicine

    John Martin Magenau, MD

    John Martin Magenau, MD

    Clinical Professor

    Hematology, Internal Medicine, Medical Oncology

    Attaphol Pawarode, MD

    Attaphol Pawarode, MD

    Clinical Associate Professor

    Hematology, Internal Medicine, Medical Oncology

    Mary Mansour Riwes, DO

    Clinical Assistant Professor

    Medical Oncology, Internal Medicine, Hematology

    Terrence Neal Wong, MD

    Assistant Professor

    Medical Oncology, Internal Medicine

    News & Stories
    sisters together 15 years ago on left and on right today
    Health Lab

    Sisters celebrate a successful bone marrow donation 15 years later

    Two sisters are celebrating 15 years of life after a bone marrow transplant. The transplant treated symptoms of Stage IV non-Hodgkin’s lymphoma and has allowed the sisters to share time together they were not sure they were going to have.
         girl on left with tan hat beanie and black shirt and green writing and on right with mom smiling same outfit and matching shirts
    Health Lab

    Teen with bone marrow transplant shares cancer journey online

    A teenager shares her rare lymphoma diagnosis and bone marrow transplant story online.
         dna strand
    Health Lab

    Research sheds new light on gene therapy for blood disorders

    Research from experts at Michigan Medicine, the Children’s Hospital of Philadelphia and Penn Medicine is breaking ground on new ways of treating blood disorders, such as sickle cell anemia, through gene therapy.
         microscopic colorful rainbow cells black background and yellow badge on bottom right and blue lettering saying lab notes
    Health Lab

    Researchers find promising new approach to stop intestinal problems caused by immune cells

    New research suggests gastrointestinal diseases caused by immune system T cells could be mitigated by bolstering a common enzyme.
         Doctor in room reaching out smiling
    Health Lab

    Treatment enhances anti-leukemia effect of bone marrow transplant, reduces recurrence, study finds

    In a clinical trial, adding interferon treatment with a bone marrow transplant bolstered outcomes for patients with advanced, high-risk leukemia.